Public Sector Pension Investment Board Vertex Pharmaceuticals Inc Transaction History

Public Sector Pension Investment Board

$15.9 Billion
Q2 2024

A detailed history of Public Sector Pension Investment Board transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Public Sector Pension Investment Board holds 9,844 shares of VRTX stock, worth $5.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,844

Previous 5,693 72.91%

Holding current value

$5.09 Million

Previous $2.38 Million 93.95%

% of portfolio

0.03%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $1.63 Million - $2.02 Million	4,151 Added 72.91%	9,844 $4.61 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $81,538 - $89,216	-200 Reduced 3.39%	5,693 $2.38 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $7.47 Million - $8.94 Million	-21,776 Reduced 78.7%	5,893 $2.4 Million
Q3 2023 Nov 22, 2023	BUY	$338.18 - $362.46 $1.02 Million - $1.09 Million	3,007 Added 12.19%	27,669 $9.62 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $1.14 Million - $1.27 Million	-3,623 Reduced 12.81%	24,662 $8.68 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $1.04 Million - $1.19 Million	-3,673 Reduced 11.49%	28,285 $8.91 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.28 Million - $1.44 Million	4,468 Added 16.25%	31,958 $9.23 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $791,368 - $882,981	2,890 Added 11.75%	27,490 $7.96 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $2.61 Million - $3.25 Million	-11,125 Reduced 31.14%	24,600 $6.93 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $1.48 Million - $1.75 Million	-6,700 Reduced 15.79%	35,725 $9.32 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $228,342 - $288,250	-1,290 Reduced 2.95%	42,425 $9.32 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $238,165 - $266,525	1,313 Added 3.1%	43,715 $7.93 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $20.1 Million - $23.7 Million	-107,322 Reduced 71.68%	42,402 $8.55 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $2.24 Million - $2.61 Million	10,814 Added 7.78%	149,724 $32.2 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $22.3 Million - $29.7 Million	107,545 Added 342.88%	138,910 $32.8 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $1.64 Million - $1.94 Million	6,400 Added 25.64%	31,365 $8.54 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $157,836 - $207,060	-700 Reduced 2.73%	24,965 $7.25 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $3.79 Million - $4.7 Million	-18,950 Reduced 42.47%	25,665 $6.11 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $890,231 - $1.2 Million	-5,340 Reduced 10.69%	44,615 $9.77 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $2.74 Million - $3.08 Million	16,459 Added 49.14%	49,955 $8.46 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $493,830 - $571,110	3,000 Added 9.84%	33,496 $6.14 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $2.83 Million - $3.37 Million	17,300 Added 131.1%	30,496 $5.61 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $182,292 - $230,652	1,200 Added 10.0%	13,196 $2.19 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $1.81 Million - $2.08 Million	-10,800 Reduced 47.38%	11,996 $2.31 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $1.27 Million - $1.48 Million	8,700 Added 61.72%	22,796 $3.87 Million
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $2.76 Million - $3.22 Million	-18,200 Reduced 56.35%	14,096 $2.3 Million
Q4 2017 Feb 02, 2018	SELL	$137.28 - $155.55 $6.93 Million - $7.86 Million	-50,500 Reduced 60.99%	32,296 $4.84 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $12.3 Million - $13.4 Million	82,796	82,796 $0

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account

Public Sector Pension Investment Board Vertex Pharmaceuticals Inc Transaction History